They successfully edited the gene in mice in vivo and their approach could also work for a range of heterozygous disease-causing SNPs.
The company was established by a co-founder of Beeologics, which was developing RNAi treatments for bee diseases before its acquisition by Monsanto.
The technology is for gene targeting using endocunleases and homologous recombination, and is the second licensing deal between the parties since April.
The scientists from UC Berkeley and UCSF said their method of introducing gene editing could lead to experiments in T cell function as well as immunotherapies.
CRISPR-EATING could enable scientists to create guide RNAs for CRISPR/Cas9 knock-out screens in organisms whose genomes are not yet sequenced.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples.